Skip to main content
. Author manuscript; available in PMC: 2012 Oct 23.
Published in final edited form as: Transplant Proc. 2009 Dec;41(10):4172–4177. doi: 10.1016/j.transproceed.2009.08.063

Table 3.

Reported Data on Association Analyses of T2DM Susceptibility Genes43 Compared to Our Results on Genetic Association With PTDM

Frequency of High-Risk Allele in Controls
 Odds Ratio (95% CI)†
Gene SNP Alleles* Prior Studies Our Study Prior Studies Our Study
TCF7L2 rs7901695 T/C 27.3 24.6 1.37 (1.31–1.43) 1.12 (0.54–2.32)
KCNJ11 rs5219 C/T 46 35.5 1.14 (1.10–1.19) 1.03 (0.52–2.01)
PPARG rs1801282 G/C 82 86.9 1.14 (1.08–1.20) 0.96 (0.39–2.34)
SLC30A8 rs13266634 T/C 61 73.9 1.12 (1.07–1.16) 1.19 (0.54–2.57)
CDKN2A/CDKN2B rs10811661 C/T 85 80.4 1.20 (1.14–1.25) 0.95 (0.43–2.13)
IGF2BP2 rs4402960 G/T 30 24.6 1.14 (1.11–1.18) 1.44 (0.67–3.07)
CDKAL1 rs7754840 G/C 36 30.4 1.12 (1.08–1.16) 1.19 (0.57–2.50)
HHEX rs1111875 A/G 52 60.8 1.13 (1.09–1.17) 1.11 (0.57–2.16)
*

Underlined and bold alleles are diabetes-associated alleles as described in prior studies.

†

Odds ratio: Unadjusted model per copy of the risk allele.